Agnieszka Oldakowska

Dr. Agnieszka Oldakowska

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Maria Pokorska-ŚpiewakMaria Pokorska-Śpiewak
Maria Pokorska-Śpiewak
ETEwa Talarek
Ewa Talarek
JPJolanta Popielska
Jolanta Popielska
KNKarolina Nowicka
Karolina Nowicka
AOAgnieszka Oldakowska
Agnieszka Oldakowska
Magdalena M MarczyńskaMagdalena M Marczyńska
Magdalena M Marczyńska
Data on the novel coronavirus disease 2019 (COVID-19) in children are limited, and studies from Europe are scarce. We analyzed the clinical severity and epidemiologic aspects of COVID-19 in consecutive children aged 0–18 years, referred with a suspicion of COVID-19 between February 1, and April 15, 2020. RT-PCR on a nasopharyngeal swab was used to confirm COVID-19. 319 children met the criteria of a suspected case. COVID-19 was diagnosed in 15/319 (4.7%) patients (8 male; mean age 10.5 years). All of them had household contact with an infected relative. Five (33.3%) patients were asymptomatic. In 9/15 (60.0%) children, the course of the disease was mild, and in 1/15 (6.7%), it was moderate, with the following symptoms: fever (46.7%), cough (40%), diarrhea (20%), vomiting (13.3%), rhinitis (6.7%), and shortness of breath (6.7%). In the COVID-19-negative patients, other infections were confirmed, including influenza in 32/319 (10%). The clinical course of COVID-19 and influenza differed significantly based on the clinical presentation. In conclusion, the clinical course of COVID-19 in children is usually mild or asymptomatic. In children suspected of having COVID-19, other infections should not be overlooked. The main risk factor for COVID-19 in children is household contact with an infected relative.

19 February 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Carlo BieńkowskiCarlo Bieńkowski
Carlo Bieńkowski
MAMałgorzata Aniszewska
Małgorzata Aniszewska
MKMonika Kowalczyk
Monika Kowalczyk
JPJolanta Popielska
Jolanta Popielska
KZKonrad Zawadka
Konrad Zawadka
Maria Pokorska-ŚpiewakMaria Pokorska-Śpiewak
Maria Pokorska-Śpiewak
Background: Toxoplasma gondii (TG) is a parasitic protozoon that may cause miscarriages or birth defects if the infection occurs during pregnancy. The study’s aim was to evaluate the risk factors associated with TG infection in pregnant women. Materials: Medical charts for all 273 pregnant women with suspected TG infection consecutively admitted to the Hospital of Warsaw between 2019 and 2020 were retrospectively analyzed. The presumptive TG diagnosis was verified by a serologic assessment of IgM and IgG titers, and IgG affinity tests. Results: The median age was 32 years (range: 19–42 years). The diagnosis of primary TG infection was confirmed in 74/273 (27.1%) women. In 114/273 (41.8%) there was evidence of past infection. In 71/273 (26%) women, an infection was excluded. In 172/273 (62%) women the recommended testing for other infectious diseases putting fetus development at risk was performed correctly. Logistic regression model analysis revealed that living in rural areas and eating raw meat were independent factors associated with increased risk of TG infection during pregnancy (OR 2.89, 95% CI: 1.42–5.9, p = 0.004; and OR 2.07, 95% CI: 1.03–4.18, p = 0.04, respectively). Conclusions: The independent risk factors for TG infection during pregnancy include living in rural areas and eating raw meat. The physician’s educational role here is crucial for the efficient prevention of congenital toxoplasmosis.

1 August 2021 in Dermatology Reports
Verified
Journal Article
Open access
PDF file
KZKonrad Zawadka
Konrad Zawadka
AOAgnieszka Oldakowska
Agnieszka Oldakowska
We present a case of a 10-month-old boy with urticaria multiforme in the course of coronavirus disease 2019 (COVID-19). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) contributes to skin lesions in both children and adults. The main cutaneous manifestations of this infection include pseudochilblains, urticaria and maculopapular eruptions. Urticaria multiforme is a common yet underrecognized exanthem in children that is precipitated by viral infections among other causes.

5 April 2024 in Pediatria i Medycyna Rodzinna
Verified
Journal Article
Open access
PDF file
AOAgnieszka Oldakowska
Agnieszka Oldakowska
Maria Pokorska-ŚpiewakMaria Pokorska-Śpiewak
Maria Pokorska-Śpiewak
Magdalena M MarczyńskaMagdalena M Marczyńska
Magdalena M Marczyńska
Vaccines are an extremely effective primary prevention tool recommended for routine use in children worldwide. Vaccination is crucial for patients with underlying diseases, including children living with HIV, because of their increased risk of morbidity and mortality from various vaccine-preventable diseases. Complex care for patients living with HIV includes antiretroviral therapy (which has dramatically improved survival), prophylaxis and treatment of common infections, prophylaxis and treatment of opportunistic infections, and vaccination. Immunisation is generally safe and beneficial for children living with HIV, although HIV-induced immune suppression reduces the benefits. All inactivated vaccines, whether killed whole organism or subunit, recombinant, toxoid, polysaccharide or conjugate (which includes diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type b, hepatitis B, hepatitis A, Streptococcus pneumoniae vaccines, Neisseria meningitidis, influenza, HPV), can be administered safely. Live attenuated measles–mumps–rubella and varicella vaccines are indicated in children without severe immunodeficiency. The Bacillus Calmette–Guérin vaccine is contraindicated due to the risk of disseminated BCG infection. Although a live attenuated influenza vaccine is available, it is contraindicated for people living with HIV because of the paucity of safety data and the availability of alternative vaccines. The study reviews the current paediatric immunisation recommendations in HIV infection in Poland. Additionally, we focus on vaccine effectiveness, especially HBV protection based on anti-Hbs antibodies.

22 August 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
Anna DobrzenieckaAnna Dobrzeniecka
Anna Dobrzeniecka
ETEwa Talarek
Ewa Talarek
MAMałgorzata Aniszewska
Małgorzata Aniszewska
BKBarbara Kowalik-Mikołajewska
Barbara Kowalik-Mikołajewska
AOAgnieszka Oldakowska
Agnieszka Oldakowska
Maria Pokorska-ŚpiewakMaria Pokorska-Śpiewak
Maria Pokorska-Śpiewak
Following successful neonatal HBV vaccination and perinatal screening, pediatric hepatitis B has become uncommon in Central Europe. However, migration and complex clinical scenarios are reshaping its epidemiology. We aimed to characterize the clinical course, disease phases, and treatment eligibility of children with HBV infection. This retrospective single-center study included patients aged 0 to <18 years referred to a tertiary pediatric infectious diseases center in Warsaw, Poland, between January 2016 and June 2026. Demographic, clinical, and laboratory data were analyzed, and patients were classified according to the 2025 EASL guidelines. Sixteen children were included. New referrals tripled from 2016–2020 (n = 3) to 2021–2026 (n = 9), and 50% were refugees, predominantly from Ukraine. Vertical transmission accounted for 44% of infections, whereas 25% were iatrogenic. According to the 2025 EASL criteria, 38% (6/16) of patients were unclassifiable. Occult HBV infection was identified in 31%, while only 13% (2/16) received analogue therapy because of restrictive national treatment criteria. One adolescent developed liver fibrosis (7.6 kPa), likely related to metabolic steatohepatitis. Contemporary pediatric HBV management might require adaptation to changing epidemiology, recognition of the limitations of adult-derived disease phase classifications, and prevention of HBV reactivation during immunosuppression.